2542 related articles for article (PubMed ID: 27472390)
21. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
[TBL] [Abstract][Full Text] [Related]
23. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
Yang YT; Jiang JH; Yang HJ; Wu ZJ; Xiao ZM; Xiang BD
Sci Rep; 2018 Feb; 8(1):2535. PubMed ID: 29416061
[TBL] [Abstract][Full Text] [Related]
24. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
25. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
26. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
27. Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection.
Hung HC; Lee JC; Cheng CH; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):559-569. PubMed ID: 28846835
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
[TBL] [Abstract][Full Text] [Related]
29. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.
Liao R; Tang ZW; Li DW; Luo SQ; Huang P; Du CY
World J Surg Oncol; 2015 Sep; 13():265. PubMed ID: 26328917
[TBL] [Abstract][Full Text] [Related]
30. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
[TBL] [Abstract][Full Text] [Related]
32. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
33. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
Pang Q; Zhou L; Qu K; Cui RX; Jin H; Liu HC
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):60-70. PubMed ID: 29189392
[TBL] [Abstract][Full Text] [Related]
34. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Zhang T; Liu Z; Zhao X; Mao Z; Bai L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
[No Abstract] [Full Text] [Related]
36. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
38. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
Mano Y; Shirabe K; Yamashita Y; Harimoto N; Tsujita E; Takeishi K; Aishima S; Ikegami T; Yoshizumi T; Yamanaka T; Maehara Y
Ann Surg; 2013 Aug; 258(2):301-5. PubMed ID: 23774313
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Mori K; Uesaka K
Br J Surg; 2016 Jun; 103(7):891-8. PubMed ID: 27005995
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma.
Xu Y; Yuan X; Zhang X; Hu W; Wang Z; Yao L; Zong L
Medicine (Baltimore); 2021 Jun; 100(25):e26506. PubMed ID: 34160470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
